Select Publications
Conference Papers
2012, 'Randomized phase III study of erlotinib versus observation in patients with no evidence of disease progression after first-line platin-based chemotherapy for ovarian carcinoma: A GCIG and EORTC-GCG study.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, presented at 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 01 June 2012 - 06 June 2012, http://dx.doi.org/10.1200/jco.2012.30.18_suppl.lba5000
,2008, 'Renal function in the elderly', in Cancer Forum, pp. 11 - 16
,2007, 'Chemotherapy in elderly patients with renal insufficiency. Recommendations of the International Society of Geriatric Oncology (SIOG)', in EJC SUPPLEMENTS, PERGAMON-ELSEVIER SCIENCE LTD, SPAIN, Barcelona, pp. 174 - 174, presented at 14th European Cancer Conference (ECCO 14), SPAIN, Barcelona, 23 September 2007 - 27 September 2007, http://dx.doi.org/10.1016/S1359-6349(07)70726-7
,2007, 'Renal insufficiency in elderly cancer patients: International Society of Geriatric Oncology (SIOG) clinical practice recommendations.', in EJC SUPPLEMENTS, PERGAMON-ELSEVIER SCIENCE LTD, SPAIN, Barcelona, pp. 175 - 175, presented at 14th European Cancer Conference (ECCO 14), SPAIN, Barcelona, 23 September 2007 - 27 September 2007, http://dx.doi.org/10.1016/S1359-6349(07)70729-2
,2004, 'Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with advanced epithelial ovarian cancer. A phase II trial of sequential doublets. (GO-FIRST).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, LA, New Orleans, pp. 457S - 457S, presented at 40th Annual Meeting of the American-Society-of-Clinical-Oncology, LA, New Orleans, 05 June 2004 - 08 June 2004, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000223512401812&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2002, 'Gastro-oesophageal complications in patients receiving cancer therapy: The role of proton pump inhibitors', in European Journal of Gastroenterology and Hepatology
,Conference Abstracts
2022, 'Regional Victorian trials alliance: Linkages, Innovation, Special populations, Equity (ReViTALISE) project: Addressing disparity in regional populations', in Asia Pacific Journal of Clinical Oncology, Wiley, Vol. 18, pp. 87 - 87, presented at COSA's 49th Annual Scientific Meeting, 02 November 2022 - 04 November 2022, https://onlinelibrary.wiley.com/doi/10.1111/ajco.13868
,2022, 'Solving unknown primary cancer - Earlier diagnosis (SUPER-ED): A stepped wedge cluster randomised controlled trial implementing a Model of Care to support earlier diagnosis', in Asia Pacific Journal of Clinical Oncology, Wiley, Vol. 18, pp. 143 - 144, presented at COSA's 49th Annual Scientific Meeting, 02 November 2022 - 04 November 2022, https://onlinelibrary.wiley.com/doi/10.1111/ajco.13869
,2022, 'Changing landscape of lung cancer survival in a regional Australian centre', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 160 - 160, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000871956500246&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'Geriatric assessment (GA) in the instagram era: Adding photographs to electronic ga to enhance supportive care (ESC) of older adults with cancer', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 224 - 224, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000871956500384&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'Stigma and ageism - The challenges of delivering appropriate care to older adults with NSCLC', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 105 - 105, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000871956500135&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'The utility of molecular tumour profiling for patients with advanced cancer in a regional Australian setting', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 151 - 151, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000871956500225&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Durability of response to immune checkpoint inhibitors (ICI) in metastatic Merkel cell carcinoma (mMCC) after treatment cessation.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, Vol. 39, http://dx.doi.org/10.1200/JCO.2021.39.15_suppl.9543
,2021, 'Phase 2 study of anastrozole in patients with estrogen receptor/progesterone receptor positive recurrent low-grade endometrial stromal sarcomas: The PARAGON trial (ANZGOG 0903)', in Gynecologic Oncology, Vol. 161, pp. 160 - 165, http://dx.doi.org/10.1016/j.ygyno.2021.02.016
,2020, 'MONARCC: A randomized phase II study of panitumumab monotherapy and panitumumab (pan) plus 5 Fluorouracil (FU) as first-line therapy for RAS and BRAF wild type metastatic colorectal cancer (mCRC): An AGITG clinical trial', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, Vol. 38, presented at Gastrointestinal Cancers Symposium of the American-Society-of-Clinical-Oncology, CA, San Francisco, 23 January 2020 - 25 January 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530922700257&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Exercise and androgen deprivation therapy: Current practice and future direction at a regional cancer centre', in Asia Pacific Journal of Clinical Oncology, Wiley, Adelaide, pp. 198 - 198, presented at 2019 COSA 46th Annual Scientific Meeting, Adelaide, 12 November 2019 - 14 November 2019, http://dx.doi.org/10.1111/ajco.13263
,2019, 'Clinical impact of tissue of origin testing and mutation profiling in the Solving Unknown Primary Cancer (SUPER) national prospective study: Experience of the first two years.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, Vol. 37, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 31 May 2019 - 04 June 2019, http://dx.doi.org/10.1200/JCO.2019.37.15_suppl.3072
,2017, 'INCORPORATING GERI-ONCOLOGY ASSESSMENTS IN GU RESEARCH', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 13, pp. 39 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000427541700040&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,Preprints
2023, Association between Antihypertensive Medicine Use and Risk of Ovarian Cancer in Women Aged 50 Years and Older, http://dx.doi.org/10.2139/ssrn.4414764
,2022, DNA sequencing and gene-expression profiling assists in making a tissue of origin diagnosis in cancer of unknown primary, http://dx.doi.org/10.1101/2022.06.24.22276729
,